I’m not sure exactly when it happened, but at some point, I stopped putting on a costume and going trick-or-treating for Halloween. Years passed, and with the arrival of my children, I found myself happily joining them in their various celebrations of the holiday. They may eventually outgrow it like…
Read more
Enrollment is complete for the randomized part of ENHANCE, a large clinical trial testing a new dosing schedule for Briumvi (ublituximab-xiiy) in adults with relapsing forms of multiple sclerosis (MS), developer TG Therapeutics announced. This part of the Phase 3b ENHANCE study (NCT05877963) is specifically testing whether…
Eating more carbohydrates significantly increases the risk of developing multiple sclerosis (MS), particularly among women and people younger than 60, according to a study based on data from the U.K. “Higher intakes of total carbohydrates, total sugars, fiber, fructose, and glucose were significantly associated with increased MS risk, with…
Metis Biotech‘s experimental oral therapy MTS-004 was safe and eased symptoms of pseudobulbar affect (PBA), a neurological condition marked by bouts of sudden, involuntary, and inappropriate laughter or crying, in people with multiple sclerosis (MS) and other neurological disorders. That’s according to data from a Phase 3 clinical…
As I sit down at my desk to write this, tears are streaming down my face. My mind, soul, body, and heart are beyond wounded from living with relapsing-remitting multiple sclerosis (MS). This burden that I bear has taken a toll on me like nothing else. I ask myself,…
Get regular updates to your inbox.
